Mayo Clinic - Gregory L Repass MD<br>Mayo Clinic - Glen T Robinson MD<br>Mayo Clinic - Gudni Thorsteinsson MD<br>Mayo Clinic - Hector Robles MD<br>Mayo Clinic - Harshal Shah MD<br>Mayo Clinic - Hollie Hickman Do<br>Mayo Clinic - Helen K Jorn MD<br>Mayo Clinic - Gregory T Frey MD<br>Mayo Clinic - Horacio J Asbun MD<br>Mayo Clinic - Han Win Tun MD<br>Mayo Clinic - Heidi N Hepp MD<br>Mayo Clinic - Gregory A Broderick MD<br>Mayo Clinic - Heidi Ko Chua MD<br>Mayo Clinic - Grettel Wentling MD<br>Mayo Clinic - Harvey D Cassidy MD
Phone:
(904) 953-2000 (Phone)
Categories:
Internal Medicine Physicians & Surgeons, Physicians & Surgeons, Sports Medicine Physicians & Surgeons, ...
Professional information
Dr. Han W Tun, Jacksonville FL - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Mayo Clinic 4500 San Pablo Rd S, Jacksonville 32224 (904) 953-2000 (Phone)
Certifications:
Hematology, 2001, Internal Medicine, 1998, Medical Oncology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Mayo Clinic 4500 San Pablo Rd S, Jacksonville 32224 Mayo Clinic 4500 San Pablo Rd, Jacksonville 32224
Han Win Tun, Jacksonville FL
Specialties:
Internal Medicine, Hepatology, Hematology, Hematology & Oncology, Medical Oncology, Hematology
Work:
Mayo Clinic hospital 4500 San Pablo Rd S, Jacksonville, FL 32224
Education:
Institute Of Medicine I (1990) Hematology & Oncology
Combination Therapy For Chemoresistant Cancers
US Patent:
2013024, Sep 19, 2013
Filed:
Sep 26, 2012
Appl. No.:
13/627848
Inventors:
Han Win Tun - Jacksonville FL, US Simon James Cooper - Jacksonville FL, US Laura Ann Marlow - Jacksonville FL, US
Assignee:
Celgene Corporation - Summit NJ
International Classification:
A61K 38/00, C12Q 1/68, G01N 33/574, A61K 31/706
US Classification:
514 199, 435 612, 435 792, 435 74
Abstract:
Methods of treating, preventing or managing triple negative breast cancer (TNBC) or clear cell renal cell carcinoma (ccRCC) are disclosed. The methods encompass the administration of an HDAC inhibitor romidepsin in combination with a cytidine analog. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods provided herein are also disclosed.